Consistent with the recent International Agency for Research on Cancer classification of Oral Contraceptives as group 1 carcinogens, this meta-analysis suggests that OCs are associated with an increase in premenopausal breast cancer risk, especially among women who use OCs before FFTP (first full term pregnancy).
This is written for researchers and MD’s so the language is a bit dense.
There is a Mayo Clinic Proceedings report that states;
Consistent with the recent International Agency for Research on Cancer classification of Oral Contraceptives as group 1 carcinogens, this meta-analysis suggests that OCs are associated with an increase in premenopausal breast cancer risk, especially among women who use OCs before FFTP (first full term pregnancy).
This is written for researchers and MD’s so the language is a bit dense.